Table 2.
No PT-Cy |
PT-Cy |
p Value | |||
---|---|---|---|---|---|
n (%) | % (95% CI) | n (%) | % (95% CI) | ||
Left ventricular systolic dysfunction | 6 (2.1) | 2.1 (0.7–4.9) | 20 (14.3) | (8.3–19.8) | 0.001 |
Acute pulmonary edema | 4 (2.1) | 2.1 (0.7–4.9) | 9 (6.7) | (3.3–11.8) | 0.036 |
Arrhythmia | 7 (3.1) | 3.1 (1.3–6.3) | 5 (3.1) | (1–7.1) | 0.95 |
Pericarditis | 2 (0.5) | 0.5 (0–2.7) | 5 (3.8) | (1.4–8.1) | 0.09 |
Acute coronary syndrome | 1 (0.5) | 0.5 (0–2.7) | 2 (1.5) | (0.3–4.8) | 0.36 |
Cumulative incidence was used to estimate all early cardiac events, with relapse and death being the competing events.
CI = confidence interval; PT-Cy = post-transplant cyclophosphamide.